News

Degenerative Myopia: a Review of its Nature and Current Treatment

by Brian Ward, Ph.D., M.D. December 2011 Degenerative myopia deserves our recognition as one of the truly neglected areas of ophthalmology. It is reported to be the seventh ranking cause of legal blindness in the United Sates of America the fourth ranking cause in Hong Kong and the second in parts of China and Japan. [Read More]

Artificial Lighting and the Blue Light Hazard

(The Facts About Lighting and Vision) by Dan Roberts, Founding Director Macular Degeneration Support Originally published on MDSupport, updated October 3, 2011) Contents Introduction What Is Light? The Blue Light Hazard Terms Referring to Measurement of Light Types of Lamps The Problem With Full-Spectrum Lamps Market Survey Summary Discussion Safe Options Live Comparison of Representative [Read More]

Encapsulated Cell Technology (ECT)–A New Drug Delivery System

by Dan Roberts Updated March 30, 2015 A means of delivering drugs into the retina on a time release basis is being developed and proven safe and effective. It is achieved by a method called Encapsulated Cell Technology (ECT), being tested by Neurotech SA with support from the National Eye Institute (NEI), Bethesda, Maryland. A [Read More]

Stargardt Disease

by Dan Roberts (Updated May 25, 2011) Stargardt disease (also known as fundus flavimaculatus and Stargardt macular dystrophy) is the most common form of inherited juvenile macular degeneration. Inherited as an autosomal recessive trait, it is a severe form of MD that begins in late childhood, leading to legal blindness. Stargardt disease is symptomatically similar [Read More]